The study design is a non-blinded pragmatic cluster-randomized controlled trial with a single intervention. Participants with uncontrolled hypertension will be identified from a randomly selected group of primary care clinics. Participants from half of the clinics will be enrolled in the intervention arm while the others will receive usual care. Participants in the intervention arm will undergo a series of software-driven medication initiation and titration steps until they reach a blood pressure target of systolic blood pressure \< 130 mmHg and diastolic blood pressure \< 80 mmHg. Participants will be subsequently monitored for up to 12 more months.
Age
18–100
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18 years - 100 years
uncontrolled hypertension: as defined as SBP \> 140 or DBP \> 90 on 2 successive clinic visits
You may not be if
hearing impaired
visually impaired
cognitively impaired
hospice care
on hemodialysis at enrollment
New York Heart Association Class IV heart failure
Clareo Health | Technology-Enabled Remote Hypertension Management To Advance Health Equity
